4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-019815
Chief Executive Officer gave up 12,612 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-03-15 | Shares withheld for taxes | −12,612 | $1.00 | $12,612 | 2,213,367 | D |
Loading xslF345X03/doc4.xml…